# Alaunos Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 5, 2026

- Company: [Alaunos Therapeutics, Inc.](/companies/tcrt.md) (CIK 1107421)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-05
- Accepted by EDGAR: Mar 5, 2026, 16:33 ET
- Period: not reported
- Accession: 0002094682-26-000002
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1107421/000209468226000002/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1107421/000209468226000002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1107421/000209468226000002/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 5, 2026.
Source: SEC EDGAR, the filing index for accession 0002094682-26-000002. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.